Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schmidli

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods of Information in Medicine|August 6, 2010
Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trialsT Friede, H Schmidli
Statistics in Medicine|October 10, 2013
Blinded sample size re-estimation for recurrent event data with time trendsS Schneider, H Schmidli, T Friede
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage formJ Bourquin, H Schmidli, P van Hoogevest, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Pitfalls of artificial neural networks (ANN) modelling technique for data sets containing outlier measurements using a study on mixture properties of a direct compressed dosage formJ Bourquin, H Schmidli, P van Hoogevest, et al.
Pharmaceutical Development and Technology|May 1, 1997
Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical developmentJ Bourquin, H Schmidli, P van Hoogevest, et al.
Pharmaceutical Development and Technology|May 1, 1997
Application of artificial neural networks (ANN) in the development of solid dosage formsJ Bourquin, H Schmidli, P van Hoogevest, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 1998
Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage formJ Bourquin, H Schmidli, P van Hoogevest, et al.
Statistics in Medicine|September 12, 2013
A Bayesian adaptive dose selection procedure with an overdispersed count endpointL Pozzi, H Schmidli, M Gasparini, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III studyH Schmidli, B Peng, G-J Riviere, et al.
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|December 17, 2008
Effects of benazepril in the treatment of feline hypertrophic cardiomyopathy Results of a prospective, open-label, multicenter clinical trialC N Amberger, O Glardon, T Glaus, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods of Information in Medicine|August 6, 2010
Blinded sample size reestimation with negative binomial counts in superiority and non-inferiority trialsT Friede, H Schmidli
Statistics in Medicine|October 10, 2013
Blinded sample size re-estimation for recurrent event data with time trendsS Schneider, H Schmidli, T Friede
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Advantages of Artificial Neural Networks (ANNs) as alternative modelling technique for data sets showing non-linear relationships using data from a galenical study on a solid dosage formJ Bourquin, H Schmidli, P van Hoogevest, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 10, 1998
Pitfalls of artificial neural networks (ANN) modelling technique for data sets containing outlier measurements using a study on mixture properties of a direct compressed dosage formJ Bourquin, H Schmidli, P van Hoogevest, et al.
Pharmaceutical Development and Technology|May 1, 1997
Basic concepts of artificial neural networks (ANN) modeling in the application to pharmaceutical developmentJ Bourquin, H Schmidli, P van Hoogevest, et al.
Pharmaceutical Development and Technology|May 1, 1997
Application of artificial neural networks (ANN) in the development of solid dosage formsJ Bourquin, H Schmidli, P van Hoogevest, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 31, 1998
Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage formJ Bourquin, H Schmidli, P van Hoogevest, et al.
Statistics in Medicine|September 12, 2013
A Bayesian adaptive dose selection procedure with an overdispersed count endpointL Pozzi, H Schmidli, M Gasparini, et al.
British Journal of Clinical Pharmacology|June 21, 2005
Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III studyH Schmidli, B Peng, G-J Riviere, et al.
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|December 17, 2008
Effects of benazepril in the treatment of feline hypertrophic cardiomyopathy Results of a prospective, open-label, multicenter clinical trialC N Amberger, O Glardon, T Glaus, et al.
Pageof 2